Say Goodbye To These 17 Products Apple Discontinued In 2025

Apple retired 17 products in 2025 across iPhone, iPad, Mac, Apple Watch, accessories and the Vision Pro — notable removals include multiple iPhone models (iPhone 14, iPhone 15, iPhone 16 Pro/Pro Max, Plus variants and the SE), the 2022 iPad 10 and M2 iPad Air, Apple Watch Series 10/SE/Ultra 2, and the first‑generation Vision Pro. Replacements and upgrades include the iPhone 16e and iPhone 17/17 Pro lineup, A16/M3 iPad updates, MacBook Air M4, Mac Studio with M4 Max and M3 Ultra, MacBook Pro with M5, AirPods Pro 3, Qi2.2 MagSafe and a Vision Pro M5 — a product rationalization that emphasizes Apple Intelligence and incremental AR/AI investments. The article contains no revenue or earnings figures; the changes signal a modest near‑term shift in hardware mix but are unlikely to be market‑moving without sales or guidance data, while Vision/AR adoption remains a strategic watch item.

Analysis

Market structure: Apple’s wide product pruning (discontinuing 17 SKUs) tightens its retail SKU mix and signals an ASP tilt toward Apple Intelligence–enabled devices; expect blended iPhone ASP to rise ~2–5% over the next 2–4 quarters as legacy low‑price SE/Plus models are removed and new hardware (Pro, vapor‑chamber cooling) supports higher margins. Component winners are high‑end silicon and RF suppliers (TSM, AVGO, QCOM) and AR/VCSEL suppliers (LITE); legacy accessory/secondary market sellers (refurbishers, low‑end Android OEMs) are losers. Retail inventory days should compress into Q1 2026 if channel migration to fewer SKUs continues, improving working‑capital flow for AAPL.

Risk assessment: Key tail risks are (1) a stall/delay in Apple Intelligence integration that suppresses service monetization (probability medium; impact high), (2) supply shocks at TSMC or geopolitical export controls (low probability; high impact), and (3) regulatory actions on App Store/AI that could cut services margin (low‑medium). Immediate (days) impact is muted; short term (weeks–months) watch December holiday sell‑through and guidance; long term (4–18 months) depends on Apple’s AR/AI roadmap and an allegedly large 2026 Mac/iPhone refresh cadence.

Trade implications: Direct play: establish a 2–3% long AAPL position into Jan–Mar 2026 to capture ASP and services tailwinds; hedge with a 0.5% position in 3‑month OTM puts (5–7% OTM) to limit downside to black‑swan events. Supplier exposure: add 1–2% long in TSM (TSM) or Broadcom (AVGO) given chip content lift; size Lumentum (LITE) at 0.5–1% as a thematic AR/VCSEL call. Options: consider a calendar call spread on AAPL around Feb earnings or WWDC 2026 to buy time premium while capping cost.

Contrarian angles: Consensus assumes incremental software/AI gains are priced; what’s missed is the potential for a >3ppt gross margin expansion if higher‑margin hardware mix and services adoption accelerate—a 12–18 month re-rating catalyst. Conversely, the market may be underestimating Vision Pro/AR execution risk; if AR sales disappoint, AR suppliers could see >20% revenue compression versus consensus. Historical parallels: Apple’s SKU rationalizations (iPhone SE retirements, iPad short cycles) preceded material margin recoveries within 2–6 quarters; monitor sell‑through and Apple’s services RPM per active device for confirmation.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in AAPL (use shares or synthetic long) between now and end‑Jan 2026 to capture ASP/margin upside; set a stop at -12% from entry and trim 50% if shares rise +18% to lock gains into the next product cycle.
• Allocate 1–2% to semiconductor suppliers: buy TSM (0.8–1.2%) and AVGO (0.8–1%) as differentiated exposure to Apple silicon and RF content increases; sell 25% of these positions if TSM/AVGO outperform AAPL by >15% in 90 days.
• Buy a 3‑month AAPL call calendar (long 3‑6 month near‑ATM calls, short 6–8 week near‑ATM calls) sized ~0.5% notional to play event gamma around Feb earnings/WWDC 2026; cap max premium and exit if IV rises >30% to avoid overpaying.
• Take a 0.5–1% hedge via AAPL 3‑month puts 5–7% OTM (or buy a 5% OTM put spread) to limit tail downside during a regulatory/supply‑shock window (monitor Reuters/FT for regulatory headlines over next 60 days).